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Abstract 
The aim of this study was to investigate the relationship between symptoms of autism 
spectrum disorder (ASD) and performance on measures of set-shifting and central 
coherence in a sample of females with anorexia nervosa (AN). Ninety-nine females aged 
12 to 47, recruited from inpatient and day patient eating disorder services, were assessed 
with the Autism Diagnostic Observation Schedule, 2nd edition (ADOS-2), as well as the 
Wechsler Abbreviated Scale of Intelligence, 2nd edition (WASI-II); Wisconsin Card 
Sorting Test (WCST); Rey-Osterrieth Complex Figure Test (ROCFT) and self-report 
questionnaires assessing eating disorder pathology, depression, cognitive rigidity and 
attention to detail. Individuals scoring above clinical cut-off on the ADOS-2 (N=35) 
reported significantly higher levels of cognitive rigidity than those with lower levels of 
ASD symptoms but there was no difference between groups on self-reported attention to 
detail. There group with high levels of ASD symptoms also made significantly more 
perseverative errors on the WCST but there was no association between ASD symptoms 
and performance on the ROCFT. The group who scored above cut-off on the ADOS-2 
were significantly younger than the sub-clinical groups. The presence of symptoms 
associated with ASD appears to be related to increased cognitive rigidity in females with 
AN.  
Keywords: executive function; feeding and eating disorders; autism spectrum disorder; 
neuropsychology 
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1. Introduction 
Anorexia Nervosa (AN) is a severe eating disorder characterised by low body weight, 
intense fear of gaining weight and undue influence of weight and shape on self-
evaluation (APA, 2013). It is associated with high mortality rates (Fichter and 
Quadflieg, 2016), severe physical complications (Treasure et al., 2015) and high levels 
of psychiatric co-morbidity (Hudson et al., 2007). One such comorbidity, which has 
received recent research attention, is Autism Spectrum Disorder (ASD). ASD is a 
pervasive developmental, dimensional disorder defined by difficulties with social 
interaction and communication and repetitive, restricted behaviours and interests (APA, 
2013). While ASD tends to affect more males than females (Brugha et al., 2011), the 
opposite gender ratio to AN (Micali et al., 2013), it has been found to be over-
represented in the predominantly female AN adult populations (Huke et al., 2013).  
 
While several studies have focused on the presence of ASD or ASD symptoms in AN 
(see Westwood and Tchanturia, 2017; Westwood et al., 2015 for reviews), others have 
examined specific similarities, both in terms of neuropsychological profiles and 
socioemotional difficulties between the two disorders (Oldershaw et al., 2011). 
However, there is a lack of research exploring within-disorder differences in 
neuropsychological functioning in AN. Research on neuropsychological similarities has 
focused on two key neuropsychological domains in ASD, namely inefficient set-shifting 
(Tchanturia et al., 2012) and weak central coherence (Lang et al., 2016; Oldershaw et 
al., 2011). Difficulties with set-shifting may manifest as either cognitive inflexibility 
(e.g. concrete and rigid approaches to problem solving) or as inflexibility in responses 
(e.g. perseverative or stereotyped behaviours) (Roberts et al., 2007), while weak central 
coherence describes both difficulty using context to interpret information (poorer global 
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processing), and a preference for detail-focused processing (Frith, 1989). Both adults 
and young people with AN exhibit poorer global processing than healthy controls (HC), 
as do the unaffected mothers of daughters with AN (Lang, Lloyd, et al., 2015; Lang et 
al., 2014; Lang et al., 2015), supporting the idea that weak central coherence may be an 
underlying trait in AN. However, to date, few studies have examined central coherence 
or set-shifting in young people with AN and systematic reviews and meta-analysis have 
reported non-significant differences between individuals with AN and healthy controls 
(Lang et al., 2014; Lang and Tchanturia, 2014). While this may be due to limited power, 
it is also possible that AN may exacerbate cognitive rigidity and weak central coherence 
such that younger individuals present with an intermediate profile between adults with 
the disorder and healthy controls.  
 
A recent meta-analysis (Westwood et al., 2016) compared the set-shifting ability of 
individuals with either AN or ASD on a commonly used measure of cognitive 
flexibility, the Wisconsin Card Sorting Test (WCST; Heaton et al., 1993). Meta-
regression indicated no effect of diagnosis (ASD or AN) on test performance in adults, 
with both AN and ASD groups making significantly more perseverative errors (PEs) 
than HCs. In children, however, there was a non-significant trend for children with ASD 
to perform worse than those with AN. This suggests that there may be differences 
between the disorders in the way that difficulties with set-shifting develop. It could also 
be that the presence of other psychiatric symptoms, including depression which is 
highly co-morbid with AN (Blinder et al., 2006), may exacerbate poorer performance 
on neuropsychological tasks (Giel et al., 2012), and difficulties with set-shifting have 
been implicated in major depressive disorder (e.g., Austin, et al., 2001). The presence of 
high levels of depression in AN may also exacerbate the challenge of recognising ASD 
5 
 
in AN, as individuals with high levels of depressive symptoms may erroneously score 
higher on measures of ASD (Westwood et al., 2017). Thus, controlling for depression 
when exploring the relationship between neuropsychological performance and ASD 
symptoms in AN is important.  
 
Interestingly, studies with adults with AN (e.g., Westwood et al., 2017;  Vagni, et al.,  
2016) have suggested higher levels of ASD or ASD symptoms than in studies with 
younger people (Pooni et al., 2012; Postorino et al., 2017; Rhind et al., 2014; 
Westwood, Mandy, Simic and Tchanturia, 2017). This suggests that the ill-state of AN 
may exacerbate symptoms associated with ASD, such as difficulties with social 
interaction or cognitive rigidity. Outcome in AN may also be poorer when ASD is 
present (Nielsen et al., 2015; Stewart et al., 2017).  
 
Given the high treatment attrition and relapse rates in AN (Treasure et al., 2010), studies 
which identify possible barriers to treatment or sub-groups of patients who require 
specifically tailored interventions are needed. Therapies such as Cognitive Remediation 
Therapy (CRT; Tchanturia et al., 2014; Tchanturia et al., 2017) and Cognitive 
Remediation and Emotion Skills Training (CREST; Tchanturia et al., 2014; Tchanturia 
et al., 2015) aim to specifically target the cognitive and socioemotional difficulties 
observed in both AN and ASD. However, it is not yet known whether individuals with 
both AN and elevated ASD symptoms have a unique neuropsychological profile and 
thus, whether interventions such as these would be particularly beneficial for this sub-
group. Given the difference in findings between adults and young people in set-shifting, 
central coherence and ASD symptoms, examining within-group differences in these 
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domains will help determine whether there are specific sub-groups of individuals with 
AN who may benefit from specifically-tailored treatment approaches.  
 
1.1 Aim 
The aim of the current study was to explore the relationship between ASD symptoms 
and cognitive style, particularly in the domains of set-shifting and central-coherence in 
females with AN. Specifically, the study aims were as follows: 
I. Investigate whether elevated ASD symptoms are associated with difficulties 
with cognitive functioning and whether any such findings are reflected in self-
reported cognitive rigidity and attention to detail. 
II. Explore whether other factors such as age, illness duration and symptoms of 
depression are associated with different levels of ASD symptoms or 
neuropsychological performance. 
 
2. Methods 
2.1 Design and participants 
A cross-sectional design was used to assess the relationship between ASD symptoms 
and neuropsychological performance in females with AN, recruited from specialist 
eating disorder inpatient or day patient treatment programmes. All participants had a 
DSM-5 primary diagnosis of AN, given by a consultant psychiatrist (APA, 2013) before 
recruitment to the study. Participants were: a) female; b) able to provide informed 
consent, or assent if under sixteen, to participate. For participants under the age of 
sixteen, parental consent was obtained. To make the participant group as representative 
as possible, exclusions criteria were kept to a minimum and consisted of: a) non-English 
speaking; b) existing neurological condition. A total of 99 participants ranging from 12 
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to 47 years of age were recruited over a 21-month period. The study was reviewed and 
approved by the National Research Ethics Service (14/LO/2131).  
2.2 Measures  
2.2.1. Autism Diagnostic Observation Schedule, 2nd Edition (ADOS-2; Lord et al., 
2012)  
The ADOS-2 is a standardised, semi-structured assessment for ASD and is the most 
widely-used and best validated direct observation of characteristics associated with 
ASD (NICE, 2012). It focuses on the domains of social interaction, communication, 
play and imaginative use of materials and takes approximately 40 minutes to administer. 
Module 4 is designed for use with verbally fluent adolescents and adults and was used 
for all participants in the current study. The diagnostic algorithm has recently been 
revised to reflect changing diagnostic criteria and to make it more comparable to other 
ADOS-2 modules (Hus and Lord, 2014). Therefore, for the purposes of this study, the 
revised algorithm score, consisting of a combined total of Social Affect and Restricted 
and Repetitive Behaviour scores was used as a measure of ASD symptoms. The scores 
yield a cut-off which can be used to aid the clinical diagnosis of ASD. For the purposes 
of this study, this cut-off score was used to indicate the presence of elevated symptoms 
associated with ASD rather than to diagnose ASD, which requires a multimodal 
process.  
 
2.2.2. Wechsler Abbreviated Scale of Intelligence – Second Edition (WASI-II; 
Wechsler, 2011) 
The WASI-II is an individually administered assessment of intelligence, suitable for 
individuals aged 6-90 years of age. It provides scores that estimate intelligence in verbal 
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and perceptual reasoning as well as full-scale IQ. The WASI-II includes four sub-tests: 
Matrix Reasoning, Block Design, Vocabulary and Similarities.  
 
2.2.3. The Wisconsin Card Sorting Test (WCST; Heaton et al., 1993)  
The WCST involves sorting stimulus cards into one of four categories per one of three 
sorting rules: colour, shape or number. The sorting rule changes after ten consecutive 
correct sorts but participants are not informed of the correct sorting rule, or that the rule 
changes during the paradigm. Out of several different outputs which can be analysed, 
perseverative errors is considered the best output for measuring conceptual flexibility or 
SS (Lezak et al., 2012) and was therefore the outcome of set-shifting used in this study. 
Percentage of PEs was used rather than raw scores to reflect that some participants 
underwent fewer trials depending on their performance, in line with standard 
procedures. The computerised, 128 trial version of the WCST: CV4 was used; detailed 
information on this testing procedure is described by Tchanturia et al (2012).  
 
2.2.4. Rey-Osterrieth Complex Figure (ROCFT; Osterrieth, 1944) 
A measure of global processing, the ROCFT is a complex figure used in the evaluation 
of visual-spatial memory and organisation. Participants are asked to copy the figure 
onto a piece of plain paper, with only limited instructions. Scoring based on Booth’s 
(2006) method and the scoring criteria reported in detail in Lang et al (2016) was used 
to analyse the drawing strategy of the participant. This method yields three scores: An 
Order Index (OI); Style Index (SI) and Central Coherence Index (CCI), see Lang et al 
(2016) for more information. A higher CCI indicates a more global processing style. To 
check reliability, 15% of the sample was co-rated by a second rater. Interrater reliability 
was good with Cohens kappa = 0.92, p = < .001. 
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2.2.5. Detail and Flexibility Questionnaire (DFlex; Roberts et al., 2011) 
The DFlex is a 24-item, self-report questionnaire measuring two aspects of 
neurocognitive functioning: cognitive rigidity and attention to detail. This measure was 
included to determine whether any group differences in neuropsychological 
performance were reflected in self-reported cognitive style. Higher scores represent 
greater cognitive rigidity/attention to detail. Both subscales show strong discriminant 
validity and differences with large effect sizes have been found between individuals 
with eating disorders and healthy controls, and between current and recovered AN 
patients (Roberts et al., 2011). Cronbach’s alpha was .91 and .73 for the cognitive 
rigidity and attention to detail subscales, respectively.  
 
2.2.6. Eating Disorder Examination Questionnaire (EDE-Q; Fairburn and Beglin, 
1994) 
The EDE-Q contains 36 items which ask respondents to rate how often they have 
engaged in certain eating disordered behaviours or held eating disordered concerns over 
the past 28 days. The scores result in a ‘global’, or total score and four subscale scores: 
‘eating concern’, ‘weight concern’, ‘shape concern’ and ‘restriction’. The EDE-Q is 
frequently used in eating disorder research. In this study, Cronbach’s alpha was .84, 
indicating good internal reliability. The EDE-Q was used to determine whether level of 
ASD symptom was associated with eating disorder pathology.   
 
2.2.7. Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983) for 
adult participants 
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The HADS is a widely used 14-item self-rating instrument for anxiety and depression in 
patients with both physical and mental health problems. The maximum possible score 
on either subscale (anxiety/depression) is 21 and the clinical cut-off is 10. Cronbach’s 
alpha was .90 for this study.  
 
2.2.8. Mood and Feelings Questionnaires (MFQ; Angold et al., 1995) for participants 
aged 18 and under, recruited from child and adolescent services 
The MFQ is a 33-item self-report measure assessing symptoms of major depressive 
disorder in young people. Participants answer on a three-point scale, indicating whether 
a statement is not true, sometimes true or true. In this study, Cronbach’s alpha was .91. 
Measures of depression were included in an attempt to control for the effect that 
symptoms of depression may have on neuropsychological performance.  
 
2.3. Procedure 
Participants attended a testing session in which they completed the ADOS-2, the 
neuropsychological assessments and self-report questionnaires. All assessments were 
conducted by the first author, who was a trained and certified researcher, reliable in the 
administration of the ADOS-2, and were video-recorded for ease of scoring. 
Assessments were all completed in the following order: ADOS-2; WASI-II; ROCFT; 
WCST and self-report questionnaires. When assessments had to be split over two 
sessions due to participant fatigue or other commitments, the same order was 
maintained. In addition to the assessments, demographic information and weight, height 
and eating disorder duration were also recorded. For participants recruited from child 
and adolescent services (N=39), percentage of ideal body weight (%IBW) rather than 
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BMI was calculated, which expresses proportion of an individual’s optimal body 
weight, corrected for age and gender (Frampton and Wilkinson, 1999). 
2.4. Statistical Analysis 
ADOS-2 scores were not normally distributed and could not be transformed. They were 
therefore treated as categorical and participants were split into three groups: high 
autistic symptoms (at or above suggested clinical cut-off), sub-clinical autistic 
symptoms (below clinical cut-off but above 0) and no autistic symptoms (scored 0 on 
ADOS-2). Other variables were assessed for normality using histograms and the 
Shapiro-Wilk test. Eating disorder duration, age of illness onset, age and EDE-Q global 
scores were not normally distributed across all autistic symptom groups and were 
therefore transformed, as needed.  As there was a significant correlation between years 
of education and age, r = .64, p = <.001, the decision was made to only include age in 
analyses. 
To investigate any group differences in eating disorder or general psychopathology and 
demographic variables, one-way ANOVAs were run between the three ASD symptom 
groups. An ANOVA was performed to assess for group differences on %PE on the 
WCST. While age was considered as a potential covariate, the data did not meet 
assumptions for an ANCOVA, so the potential impact of age on the association between 
ASD symptoms and performance on the WCST could not be controlled for. Despite the 
data not being normally distributed it was not transformed, as one-way ANOVAs are 
considered robust to deviations from normality, particularly with relatively equal 
sample sizes (Lix et al., 1996). To examine whether elevated ASD symptoms were 
associated with lower CCI scores on the ROCFT, an ANCOVA was performed with age 
as the covariate. 
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Differences in self-reported cognitive style, as assessed by the DFlex, were also 
assessed using one-way ANOVAs. Cognitive rigidity scores were moderately 
negatively skewed so were transformed.  
Effect sizes were calculated using partial η2, with the following interpretation: small 
(0.01), medium (0.09) and large (0.25) (Cohen, 1988). As symptoms of depression were 
measured on two different questionnaires, namely the HADS from adult participants 
and the MFQ for younger participants, standardised Z scores were calculated to create 
one standardised “depression” variable. An alpha value of .05 was applied for all tests 
of statistical significance. Data was analysed using the statistical package IBM SPSS 
version 22.00.  
3. Results 
3.1. Clinical comparison between groups 
Clinical and demographic information for the three autistic symptom groups are 
displayed in Table 1. The groups differed significantly on %IBW with the no autistic 
symptom group having a higher %IBW than the sub-clinical autistic symptom group. 
The high autistic symptom group were significantly younger than the no autistic 
symptom group. There was no association between psychiatric medication use and ASD 
classification, as assessed using Chi-Squared. 
 [Insert Table 1 here] 
3.2 Associations between variables 
To examine whether factors such as age, BMI or duration of AN were associated with 
ASD symptoms, Spearman’s rank order correlations were performed between each 
variable. Age was significantly positively correlated with ADOS-2 scores and was 
therefore considered a potential confounding variable in the relationship between ASD 
symptom and cognitive functioning. ADOS-2 scores were also significantly positively 
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correlated with depression scores and with %PE on the WCST. The ROCFT CCI was 
significantly negatively correlated with %PEs so that an increase in %PEs was 
associated with a decrease in CCI on the ROCFT. All correlation coefficients can be 
viewed in the supporting file that accompanies this paper.    
3.3. Neuropsychological outcomes  
Table 2 displays the mean and standard deviations for the WCST and ROCFT 
outcomes. As not all participants completed both the WCST and the ROCFT, due to 
some individuals choosing not to participate in all parts of the assessment, the exact 
number of participants in each group for both neuropsychological assessments are 
indicated in Table 2.  
[Insert Table 2 here] 
3.2.1 WCST  
To examine whether elevated ASD symptoms were associated with difficulties with set-
shifting, a one-way ANOVA was conducted, with %PE as the dependent variable. The 
%PE score was statistically significantly different for different levels of ASD 
symptoms, Welch’s F(2,59.77) = 3.77, p = .029. Games-Howell post hoc analysis 
revealed that an increase in %PE score from 8.70 ± 3.94 in the no autistic symptom 
group to 13.35 ± 8.94 in the high autistic symptom group, an increase of 4.65 (95% CI, 
0.5 to 8.7) was statistically significant, p = . 
023. There were no other statistically significant differences between groups. Percent 
PEs, plotted against ADOS-2 scores in the three ASD symptom groups are displayed in 
Figure 1. While it was not possible to conduct an ANCOVA, Spearman’s rank order 
correlations were performed between age and %PEs for each ASD symptom group. 
There were no significant correlations between age and %PEs across any of the ASD 
symptom groups.   
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[Insert Figure 1 here] 
 
3.2.2 ROCFT 
To examine whether elevated ASD symptoms were associated with difficulties with 
central coherence, an ANCOVA was performed with age as the covariate. After 
adjusting for age, there was no statistically significant difference between groups, 
F(2,90) = .25, p = .782, partial η2 = .005. 
 
3.3. Self-reported cognitive style 
One-way ANOVAs were run to examine group differences in cognitive rigidity and 
attention to detail scores on the DFlex. Results are displayed in Table 3. Tukey’s post 
hoc analysis revealed that the difference between the no autistic symptom group and the 
sub-clinical autistic symptom group and between the sub-clinical autistic symptom 
group and the high autistic symptom groups were not statistically significant. However, 
the increase in cognitive rigidity scores between the no autistic symptom and high 
autistic symptom groups was statistically significant, p = .018.  
[Insert Table 3 here] 
4. Discussion 
This study aimed to examine the association between ASD symptoms and cognitive 
style in females with AN, specifically focusing on difficulties with set-shifting and 
central-coherence. Despite previous studies (Oldershaw et al., 2011; Westwood et al., 
2016) examining similarities between AN and ASD in terms of cognitive style, this is 
the first study to directly examine within-disorder differences between individuals with 
elevated, sub-clinical and no ASD symptoms, as defined by the recommended clinical 
cut-off on the ADOS-2. This is the largest study to use the ADOS-2 within an AN 
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population and found that a third of participants score above clinical cut-off, suggestive 
of the presence of ASD symptoms. Individuals who scored at or above the clinical cut-
off on the ADOS-2 made significantly more PEs on the WCST, indicating that 
individuals with both AN and elevated ASD symptoms have greater difficulties with 
set-shifting than individuals without these ASD symptoms. Participants scoring above 
and below cut-off on the ADOS-2 performed similarly on the central-coherence task 
(ROCFT).  
 
The age of the participants differed significantly between the three groups, with the 
HAS group being significantly younger. This may have important implications on the 
potential relationship between set-shifting ability and age in AN. In typically-
developing individuals, set-shifting ability improves through adolescence, into 
adulthood (Kalkut et al., 2009). The recent meta-analysis and meta-regression 
(Westwood et al., 2016) comparing both adult and child/adolescent groups with either 
AN or ASD with HCs on performance on the WCST found that while the performance 
of adults with either disorder was statistically comparable, there was a trend for younger 
people with ASD to perform worse than those with AN. This suggests that whereas set-
shifting may be impaired even in younger people with ASD, the presence of AN may 
cause a developmental delay or exacerbate inefficiencies in set-shifting ability.  
 
In individuals who have both AN and elevated ASD symptoms, set-shifting difficulties 
may be exacerbated beyond those caused by the presence of either ASD or AN alone. 
However, it could also be that individuals who scored above the clinical cut-off on the 
ADOS-2 represent a subgroup of individuals with extreme cognitive rigidity and social 
difficulties, rather than having co-morbid ASD. Controlling for age in analysis would 
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help account for the normal developmental trajectory of set-shifting ability. 
Longitudinal studies using full ASD diagnostic criteria are needed to further examine 
the relationship between symptoms of ASD and neuropsychological functioning in 
people with AN across the lifespan. 
 
This study did not reveal an association between the ROCFT and levels of ASD 
symptoms in females with AN. This may be due to the inclusion of a solely female 
sample. There is a clear gender disparity between ASD and AN, which may make the 
cognitive style associated with the two disorders less comparable. ASD is more 
prevalent in males (Brugha et al., 2011) whereas the opposite is true of AN (Micali et 
al., 2013). Consequently, most research examining cognitive style in ASD is conducted 
in males, so conclusions regarding the cognitive profile of females with ASD cannot be 
drawn. Limited research (Bolte et al., 2011) suggests that females with ASD may have 
fewer difficulties with executive function than their male counterparts, and may also be 
less detailed-focused. This highlights the need for studies directly comparing females 
with ASD and AN, in addition to examining disorder-specific gender differences.  
 
The self-report findings of this study, namely individuals with elevated ASD symptoms 
report significantly higher levels of cognitive rigidity but not attention to detail 
compared to those with lower levels of these symptoms, mirror the neuropsychological 
results. Although self-report cognitive rigidity, as measured by the DFlex was thought 
to reflect difficulties with SS (Roberts et al., 2011), in the current study, there was no 
significant relationship between performance on the WCST and the cognitive rigidity 
subscale of the DFlex. This was also the case for the CCI of the ROCFT, which was not 
significantly associated with the attention to detail subscale of the DFlex. These 
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findings suggest that experimental SS and self-reported cognitive styles may be 
different constructs (Lounes et al., 2011). 
 
4.1 Limitations  
While information on medication use was obtained, the possible effect of medication on 
test performance was not controlled for in analysis. As psychotropic medication may 
impact upon neuropsychological test performance (Helmes, 2016), future research 
should attempt to control for this. However, the percentage of medication use was 
similar in all ASD symptom groups and previous research using the both the WCST and 
ROCFT with young people with AN found no difference in performance between 
participants on medication and those who were medication-free (Lang et al., 2015).  
 
Given the cross-sectional design of this study, assumptions about the causal relationship 
between ASD and AN (Hiller and Pellicano, 2013) cannot be made. In addition, 
questions over the validity of using assessments tools such as the ADOS-2 with adults 
with co-morbid mental health problems (Lai et al., 2011) limit the generalisability of the 
findings of this study. As discussed, it could be that the individuals who scored above 
the ADOS-2 cut-off represented a subgroup of individuals with AN characterised by 
extreme cognitive rigidity or difficulties with social interaction, rather than having 
ASD. It is possible that other co-occurring symptoms, commonly found in individuals 
with AN, such as obsessive-compulsive disorder or alexithymia (Cederlof et al., 2015; 
Courty et al., 2015) may increase the likelihood of scoring above clinical cut-off on the 
ADOS-2, leading to “false-positive” results on its current diagnostic algorithm. In this 
study, ADOS-2- scores were significantly positively correlated with depression scores. 
While it could be that ASD symptoms increase the likelihood of experiencing 
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symptoms of depression (Matson and Williams, 2014), however, the opposite could also 
be true. The aim of this study was to assess observable symptoms associated with the 
ASD rather than to diagnose the disorder. However, until such a time that ASD can be 
confidently assessed in AN populations, the findings should be interpreted with caution.   
 
4.2 Clinical implications  
The findings of this study have important clinical implications. Given that research 
suggests that prognosis is poorer for individuals with co-occurring eating disorders and 
elevated ASD traits, (Nielsen et al., 2015; Stewart et al., 2017), services may benefit 
from tailoring specific treatments to the needs of individuals who present with elevated 
ASD symptoms. Certain interventions, such as CRT (Tchanturia et al., 2013; Tchanturia 
et al., 2014) and CREST (Tchanturia et al., 2014; Tchanturia et al., 2015) have been 
specifically designed to target the inefficient cognitive and emotional style of 
individuals with AN. If individuals with both AN and elevated ASD traits have a more 
inefficient cognitive style, they may benefit from a higher dose of these therapies or 
from treatments being tailored to account for cognitive rigidity (Tchanturia et al., 2016). 
Specifically, given the finding from this study that individuals with elevated ASD 
symptoms may have particular difficulties with set-shifting, targeting this inefficiency 
within treatment may be beneficial. However, as this is the first study to examine 
within-disorder differences in cognitive style, further studies are needed before specific 
recommendations can be made. This line of research would benefit from future studies 
comparing treatment outcomes in individuals with high and low levels of characteristics 
associated with ASD. 
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Table 1. Participant demographics and one-way ANOVA results with effect sizes.  
 HAS mean (SD) 
N = 35 
SCAS mean (SD) 
N = 37 
NAS mean (SD) 
N = 27 
p Partial η2 
effect size 
Tukey	post	hoc	tests	 
HAS	vs	SCAS SCAS	vs	NAS HAS	vs	NAS 
Age 20.43(9.33) 22.27(7.59) 23.12(7.51) .042 .06 p	=	.143 p	=	.784 p	=	.047 
Eating disorder duration 4.82(8.82) 5.74(6.46) 6.29(7.57) 554 .01    
BMI (adults) N = 14 
15.51(2.19) 
N =24  
15.80(2.02) 
N =22 
14.71(2.08) 
 
.209 
 
.05 
   
%IBW  
(young people) 
N =21 
88.51(7.19) 
N =13 
84.14(6.11) 
N =5 
94.45(9.47) 
 
.032 
 
.18 
p	=	.224 p	=	.028 p	=	.234 
EDE-Q Global Score 3.99(1.40) 3.95(1.71) 3.45(1.53) .205 .03    
Age of illness onset 15.76(5.99) 16.94(4.27) 16.89(5.26) .145 .04    
HADS depression (adults) N = 14 
12.29(5.09) 
N = 24 
9.46(4.83) 
N = 22 
8.41(4.27) .166 .04 
   
MFQ score (young people) N = 21 
71.11(14.24) 
N = 13 
71(12.95) 
N = 5 
69(24.26) 
   
Full-scale IQ 
(4 subtests) 
106.23(16.32) 109.97(11.22) 113.54(13.38) .139 .04    
Ethnicity (%White British) 66.7 84.2 77.8      
Psychiatric Medication Use (%) 33.3 38.9 27.8 χ2(2)	=	0.25,	p	=	.883.    
Antidepressants (%) 7.6 8.6 6.8    
Antipsychotics (%) 3.3 3.7 3    
Antidepressant and 
antipsychotic (%) 
6.6 7.5 5.9    
BMI = body mass index; EDE-Q = Eating Disorder Examination Questionnaire, global score; HADS = Hospital Anxiety and Depression Scale, depression subscale; HAS 
= high autistic symptoms; %IBW = percentage of ideal body weight for height (for participants recruited from child and adolescent services); NAS = no autistic symptoms; 
SCAS = sub-clinical autistic symptoms. For	age,	eating	disorder	duration,	age	of	illness onset	and	EDE-Q	global	score,	analysis	was	conducted	using	transformed	scores.	
For	depression,	analysis	was	conducted	using	standardised	Z	scores.	Statistically	significant	results	are	highlighted	in	bold.  
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Table 2. One-way ANOVA results for WCST and ROCFT outcomes with effect sizes.  
 
 HAS mean 
(SD) 
SCAS mean 
(SD) 
NAS mean 
(SD) 
p Partial η2 
effect size 
WCST outcomes N = 34 N = 34 N = 27   
Number of trials administered 97.74(21.98)  91.53(16.07) 84.19(15.47) .021 .08 
Total correct responses 68.44(12.16) 71.50(7.62) 67.37(5.71) .061 .04 
Total response errors  29.29(25.07) 20.03(13.85) 16.81(14.61) .061 .08 
Total response errors % 26.68(17.34) 20.41(9.38) 18.07(10.24) .065 .07 
Total perseverative errors 14.56(12.49) 9.68(8.00) 7.89(5.61) .027 .09 
Total perseverative errors % 13.35(8.84) 10.00(5.68) 8.70(3.94) .029 .08 
ROCFT outcomes N = 32 N = 36 N = 26   
Order Index 1.95(0.69) 1.75(0.84) 1.90(0.67) .515 .01 
Style Index 1.81(0.48) 1.13(0.52) 1.23(0.52) .739 .01 
Central Coherence Index  1.20(0.43) 1.14(0.50) 1.21(0.42) .814 .01 
HAS = high autistic symptoms; NAS = no autistic symptoms; SCAS = sub-clinical autistic symptoms; 
ROCFT = Rey Osterrieth Complex Figure Test; SD = standard deviation; WCST = Wisconsin Card 
Sorting Test. For WCST results, p values for Welch ANOVA are reported due to homogeneity of 
variance being violated; statistically significant results are highlighted in bold 
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Table 3. Self-reported cognitive style one-way ANOVA results with effect sizes. 
 NAS mean 
(SD)	
SCAS mean 
(SD)	
HAS mean 
(SD)	
p Partial 
η2effect size  
Cognitive rigidity 47.65(12.59) 51.09(12.49) 55.72(10.58) .031 .07 
Attention to detail 1.44(0.25) 46(1.44) 3.94(1.34) .309 .03 
HAS	=	high	autistic	symptoms;	NAS	=	no	autistic	symptoms;	SCAS	=	subclinical	autistic	symptoms;	SD	=	
standard	deviation.	Cognitive	rigidity	analysis	was	conducted	using	transformed	scores.	 
 
  
